Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
MLYS | US
0.65
2.44%
Healthcare
Biotechnology
30/06/2024
09/03/2026
27.24
26.84
27.47
26.00
Mineralys Therapeutics Inc. a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and associated cardiovascular diseases. It clinical-stage product candidate is lorundrostat a proprietary orally administered highly selective aldosterone synthase inhibitor for the treatment of patients with uncontrolled or resistant hypertension. The company was incorporated in 2019 and is headquartered in Radnor Pennsylvania.
View LessValue Stock (Price to Book < 3)
Strong Sharpe Ratio (> 1.2)
Price Below SMA10D
High Short-term Volatility
Smallcap (300M - 2B USD)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
50.0%1 month
52.3%3 months
49.8%6 months
57.4%-
-
2.47
-
-
-7.41
-
-
-
1.35B
1.35B
-
-
-
-
-41.62
14.21
4.67
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
4.39
Range1M
6.55
Range3M
13.56
Rel. volume
0.81
Price X volume
23.51M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Ardelyx Inc | ARDX | Biotechnology | 6.17 | 1.45B | -0.32% | n/a | 71.36% |
| Pharvaris B.V | PHVS | Biotechnology | 26.51 | 1.43B | 2.32% | n/a | 0.04% |
| Intellia Therapeutics Inc | NTLA | Biotechnology | 13.89 | 1.41B | 3.35% | n/a | 10.95% |
| ELVN | ELVN | Biotechnology | 29.73 | 1.40B | 0.99% | n/a | 0.06% |
| Innoviva Inc | INVA | Biotechnology | 22.32 | 1.40B | 1.32% | 11.32 | 67.72% |
| Kodiak Sciences Inc | KOD | Biotechnology | 25.72 | 1.35B | 3.46% | n/a | 81.94% |
| Immunome Inc | IMNM | Biotechnology | 21.33 | 1.28B | 1.38% | n/a | 1.09% |
| immatics biotechnologies GmbH | IMTX | Biotechnology | 10 | 1.19B | 1.42% | n/a | 0.00% |
| MoonLake Immunotherapeutics | MLTX | Biotechnology | 18.32 | 1.15B | 0.94% | n/a | 0.64% |
| Oculis Holding AG Ordinary shares | OCS | Biotechnology | 27.42 | 1.14B | 1.71% | n/a | 1.19% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| ARLO TECHNOLOGIES INC | ARLO | Building Products & Equipment | 14.07 | 1.41B | 1.22% | n/a | 19.46% |
| Lincoln Educational Services Corporation | LINC | Building Products & Equipment | 36.22 | 1.14B | 1.06% | 51.60 | 88.92% |
| Winnebago Industries Inc | WGO | Recreational Vehicles | 35.25 | 1.02B | -2.87% | 22.53 | 56.33% |
| Janus International Group Inc. | JBI | Building Products & Equipment | 5.39 | 783.29M | 1.89% | 11.62 | 116.21% |
| Latham Group Inc. | SWIM | Building Products & Equipment | 6.31 | 729.29M | 0.16% | 65.18 | 77.00% |
| Fox Factory Holding Corp | FOXF | Recreational Vehicles | 16.37 | 682.35M | 0.37% | 42.05 | 64.69% |
| Ennis Inc | EBF | Building Products & Equipment | 21.16 | 550.24M | -0.70% | 13.28 | 2.28% |
| Malibu Boats Inc | MBUU | Recreational Vehicles | 25.67 | 513.16M | -0.39% | n/a | 1.50% |
| ACCO Brands Corporation | ACCO | Building Products & Equipment | 3.67 | 351.58M | -6.14% | n/a | 174.23% |
| Camping World Holdings Inc | CWH | Recreational Vehicles | 7.47 | 337.11M | 1.49% | n/a | 3644.76% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -7.41 | 0.53 | Cheaper |
| Ent. to Revenue | - | 3,967.00 | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 2.47 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 49.78 | 72.80 | Lower Risk |
| Debt to Equity | - | -1.23 | - |
| Debt to Assets | - | 0.25 | - |
| Market Cap | 1.35B | 3.66B | Emerging |